Development and performance of NLISA for C-reactive protein detection based on Prussian blue nanoparticle conjugates
Analytical and Bioanalytical Chemistry · 2024
DOI: 10.1007/s00216-024-05268-y ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical and Bioanalytical Chemistry, 2024. Verfasst von Maria Nikitina und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Ecology and Genetics of Microorganisms, Urals Branch of RAS, Perm, Russia. kropanevamasha@gmail.com. Hauptthemen laut MEDLINE: C-Reactive Protein, Ferrocyanides, Limit of Detection, Nanoparticles. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Russian Science Foundation.
Abstract (Originalsprache)
Prussian blue nanoparticles (PBNPs), also called nanozymes, are very attractive as an alternative to horseradish peroxidase in immunoassay development due to their simple and low-cost synthesis, stability and high catalytic activity. Today, there is a method for highly effective PBNP synthesis based on the reduction of an FeCl3/K3[Fe(CN)6] mixture by hydrogen peroxide. However, there is a lack of research showcasing the use of these highly effective PBNPs for specific target detection in clinical settings, as well as a lack of comprehensive comparisons with conventional methods. To address this gap, we prepared diagnostic reagents based on highly effective PBNPs by modifying them using gelatin and attaching anti-C-reactive protein (CRP) monoclonal antibodies through cross-linking with glutaraldehyde. As a result, a solid-phase colorimetric immunoassay in a sandwich format (nanozyme-linked immunosorbent assay [NLISA]) using highly effective PBNPs as a label for CRP detection has been demonstrated for the first time. The assay demonstrated a detection limit of 21.8 pg/mL, along with acceptable selectivity, precision (CV < 25%) and accuracy (the recovery index was within acceptable limits (75-125%) for LLOQ /ULOQ range. The analytical performance of this method is on par with sensitive assays developed in the last 5 years. Notably, the results obtained from NLISA align with those from an immunofluorescence assay conducted by a certified clinical laboratory. Furthermore, this study underscores the technological challenges involved in constructing an analysis that necessitate further exploration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Ecology and Genetics of Microorganisms, Urals Branch of RAS, Perm, Russia. kropanevamasha@gmail.com.
- Biology Faculty, Perm State University, Perm, Russia. kropanevamasha@gmail.com.
- Institute of Ecology and Genetics of Microorganisms, Urals Branch of RAS, Perm, Russia.
- Biology Faculty, Perm State University, Perm, Russia.
Förderung
- Russian Science Foundation
Zitieren
APA
Nikitina, M., Khramtsov, P., Bochkova, M., & Rayev, M. (2024). Development and performance of NLISA for C-reactive protein detection based on Prussian blue nanoparticle conjugates. Analytical and Bioanalytical Chemistry. https://doi.org/10.1007/s00216-024-05268-y
Vancouver
Nikitina M, Khramtsov P, Bochkova M, Rayev M. Development and performance of NLISA for C-reactive protein detection based on Prussian blue nanoparticle conjugates. Analytical and Bioanalytical Chemistry. 2024. doi:10.1007/s00216-024-05268-y
BibTeX
@article{Nikitina2024,
author = {Nikitina, Maria and Khramtsov, Pavel and Bochkova, Maria and Rayev, Mikhail},
title = {Development and performance of NLISA for C-reactive protein detection based on Prussian blue nanoparticle conjugates},
journal = {Analytical and Bioanalytical Chemistry},
year = {2024},
doi = {10.1007/s00216-024-05268-y}
}
EUVIMED